Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug–Drug Interaction Between Clopidogrel and Dasabuvir

Dasabuvir, a nonnucleoside NS5B polymerase inhibitor, is a sensitive substrate of cytochrome P450 (CYP) 2C8 with a potential for drug–drug interaction (DDI) with clopidogrel. A physiologically based pharmacokinetic (PBPK) model was developed for dasabuvir to evaluate the DDI potential with clopidogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shebley, M, Fu, W, Badri, P, Bow, DAJ, Fischer, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599937/
https://www.ncbi.nlm.nih.gov/pubmed/28411400
http://dx.doi.org/10.1002/cpt.689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599937/
https://www.ncbi.nlm.nih.gov/pubmed/28411400
http://dx.doi.org/10.1002/cpt.689

Ejemplares similares